GURUFOCUS.COM » STOCK LIST » Real Estate » REITs » W.P. Carey Inc (NYSE:WPC) » Definitions » Operating Income

W.P. Carey (W.P. Carey) Operating Income : $815 Mil (TTM As of Dec. 2023)


View and export this data going back to 1998. Start your Free Trial

What is W.P. Carey Operating Income?

W.P. Carey's Operating Income for the three months ended in Dec. 2023 was $200 Mil. Its Operating Income for the trailing twelve months (TTM) ended in Dec. 2023 was $815 Mil.

Operating Margin % is calculated as Operating Income divided by its Revenue. W.P. Carey's Operating Income for the three months ended in Dec. 2023 was $200 Mil. W.P. Carey's Revenue for the three months ended in Dec. 2023 was $412 Mil. Therefore, W.P. Carey's Operating Margin % for the quarter that ended in Dec. 2023 was 48.50%.

Good Sign:

W.P. Carey Inc operating margin is expanding. Margin expansion is usually a good sign.

W.P. Carey's 5-Year average Growth Rate for Operating Margin % was 1.10% per year.

Operating Income or EBIT is linked to Return on Capital for both regular definition and Joel Greenblatt's definition. W.P. Carey's annualized ROC % for the quarter that ended in Dec. 2023 was 4.09%. W.P. Carey's annualized ROC (Joel Greenblatt) % for the quarter that ended in Dec. 2023 was %.


W.P. Carey Operating Income Historical Data

The historical data trend for W.P. Carey's Operating Income can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

W.P. Carey Operating Income Chart

W.P. Carey Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Operating Income
Get a 7-Day Free Trial Premium Member Only Premium Member Only 534.29 553.80 624.57 699.94 814.72

W.P. Carey Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Operating Income Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 182.63 181.07 222.31 211.29 200.05

W.P. Carey Operating Income Calculation

Operating Income, is the profit a company earned through operations. All expenses, including cash expenses such as cost of goods sold (COGS), research & development, wages, and non-cash expenses, such as depreciation, depletion and amortization, have been deducted from the sales.

Operating Income for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $815 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


W.P. Carey  (NYSE:WPC) Operating Income Explanation

1. Operating Income or EBIT is linked to Return on Capital for both regular definition and Joel Greenblatt's definition.

W.P. Carey's annualized ROC % for the quarter that ended in Dec. 2023 is calculated as:

ROC % (Q: Dec. 2023 )
=NOPAT/Average Invested Capital
=Operating Income * ( 1 - Tax Rate % )/( (Invested Capital (Q: Sep. 2023 ) + Invested Capital (Q: Dec. 2023 ))/ count )
=800.196 * ( 1 - 8.68% )/( (18391.786 + 17305.801)/ 2 )
=730.7389872/17848.7935
=4.09 %

where

Invested Capital(Q: Sep. 2023 )
=Total Assets - Accounts Payable & Accrued Expense - Excess Cash
=Total Assets - Accounts Payable & Accrued Expense - ( Cash, Cash Equivalents, Marketable Securities - max(0, Total Current Liabilities - Total Current Assets+Cash, Cash Equivalents, Marketable Securities))
=18630.239 - 872.296 - ( 136.438 - max(0, 872.296 - 238.453+136.438))
=18391.786

Invested Capital(Q: Dec. 2023 )
=Total Assets - Accounts Payable & Accrued Expense - Excess Cash
=Total Assets - Accounts Payable & Accrued Expense - ( Cash, Cash Equivalents, Marketable Securities - max(0, Total Current Liabilities - Total Current Assets+Cash, Cash Equivalents, Marketable Securities))
=17976.783 - 808.082 - ( 633.86 - max(0, 808.082 - 670.982+633.86))
=17305.801

Note: The Operating Income data used here is four times the quarterly (Dec. 2023) data.

2. Joel Greenblatt's definition of Return on Capital:

W.P. Carey's annualized ROC (Joel Greenblatt) % for the quarter that ended in Dec. 2023 is calculated as:

ROC (Joel Greenblatt) %(Q: Dec. 2023 )
=EBIT/Average of (Net fixed Assets + Net Working Capital)
=EBIT/Average of (Property, Plant and Equipment+Net Working Capital)
     Q: Sep. 2023  Q: Dec. 2023
=EBIT/( ( (Property, Plant and Equipment + Net Working Capital) + (Property, Plant and Equipment + Net Working Capital) )/ count )
=920.608/( ( (0 + max(-770.281, 0)) + (0 + max(-770.96, 0)) )/ 2 )
=920.608/( ( 0 + 0 )/ 2 )
=920.608/0
= %

where Working Capital is:

Working Capital(Q: Sep. 2023 )
=(Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Defer. Rev. + Other Current Liabilities)
=(0 + 0 + 102.015) - (872.296 + 0 + 0)
=-770.281

Working Capital(Q: Dec. 2023 )
=(Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Defer. Rev. + Other Current Liabilities)
=(0 + 0 + 37.122) - (808.082 + 0 + 0)
=-770.96

When net working capital is negative, 0 is used.

Note: The EBIT data used here is four times the quarterly (Dec. 2023) EBIT data.

3. Operating Income is also linked to Operating Margin %:

W.P. Carey's Operating Margin % for the quarter that ended in Dec. 2023 is calculated as:

Operating Margin %=Operating Income (Q: Dec. 2023 )/Revenue (Q: Dec. 2023 )
=200.049/412.437
=48.50 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

4. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Operating Income growth rate using Operating Income per share data.


Be Aware

Compared with a company's EBITDA margin, Operating Margin can be manipulated by adjusting the rate of depreciation, depletion and amortization (DDA).

If a company is facing competition, its Operating Margin may decline. Often the Operating Margin declines well before the company's revenue or even profit decline. Therefore, Operating Margin is a very important indicator of whether the company is facing problems.

For instance, by 2012, Nokia (NOK)'s problems were well known and its stock had lost more than 90% of its market value since 2007. But Nokia's Operating Margin had already been in decline since 2002, although its earnings per share were still rising. Investors who paid attention to Operating Margin would have avoided this huge loss. The same can be said for Research-in-Motion (RIMM).

Therefore, Operating Margin is a very important screening filter for GuruFocus. GuruFocus's Buffett-Munger screener requires that the profit margin is either consistent or expanding. The Model Portfolio of the Buffett-Munger screener has outperformed the market every year since inception in 2009.


W.P. Carey Operating Income Related Terms

Thank you for viewing the detailed overview of W.P. Carey's Operating Income provided by GuruFocus.com. Please click on the following links to see related term pages.


W.P. Carey (W.P. Carey) Business Description

Traded in Other Exchanges
Address
One Manhattan West, 395 9th Avenue, 58th Floor, New York, NY, USA, 10001
W.P. Carey Inc is a real estate investment trust principally involved in the ownership of properties located in the U.S., Western Europe, and Northern Europe. W.P. Carey organizes its operations into Real Estate and Investment Management segments. The vast majority of the company's income is derived from its Real Estate division in the form of lease revenue from long-term agreements with companies. W.P. Carey's real estate portfolio is primarily comprised of single-tenant office, industrial, warehouse, and retail facilities located around the world. most of the company's revenue comes from properties in the USA. The company's Investment Management unit generates revenue from providing real estate advisory and portfolio management services to other REITs.
Executives
Brian H Zander officer: Chief Accounting Officer C/O W. P. CAREY INC., ONE MANHATTAN WEST, 395 9TH AVE., 58 FL, NEW YORK NY 10001
Mark A Alexander director C/O W. P. CAREY INC., 395 9TH AVENUE, 58TH FLOOR, NEW YORK, NEW YORK NY 10001
Talma Stheeman Mechthild Elisabeth director C/O W. P. CAREY INC, ONE MANHATTAN WEST, 395 9TH AVE., 58 FL, NEW YORK NY 10001
Beier Constantin H. director C/O W. P. CAREY INC., ONE MANHATTAN WEST 395 9TH AVENUE, 58 FL, NEW YORK, NEW YORK NY 10001
Gino M. Sabatini officer: Managing Director C/O W. P. CAREY & CO. LLC, 50 ROCKEFELLER PLAZA, NEW YORK NY 10020
John J Park officer: President C/O W. P. CAREY INC., ONE MANHATTAN WEST, 395 9TH AVE. 58TH FL, NEW YORK NY 10001
Jason E. Fox director, officer: CEO C/O W. P. CAREY INC., ONE MANHATTAN WEST, 395 9TH AVE., 58 FL, NEW YORK NY 10001
Arjun Mahalingam officer: Chief Accounting Officer C/O W. P. CAREY INC., 50 ROCKEFELLER PLAZA, NEW YORK NY 10020
Toniann Sanzone officer: CFO C/O W. P. CAREY INC., ONE MANHATTAN WEST, 395 9TH AVE., 58 FL, NEW YORK, NEW YORK NY 10001
Brooks G. Gordon officer: Managing Director C/O W. P. CAREY INC., 50 ROCKEFELLER PLAZA, NEW YORK NY 10020
Tonit M Calaway director HARLEY-DAVIDSON MOTOR COMPANY, 3700 WEST JUNEAU AVENUE, MILWAUKEE WI 53208
Margaret G Lewis director 200 COMMERCE STREET, SMITHFIELD VA 23430
Robert J Flanagan director C/O SAGENT PHARMACEUTICALS, INC., 1901 NORTH ROSELLE ROAD, SUITE 700, SCHAUMBURG IL 60195
Peter Farrell director C/O W. P. CAREY INC., ONE MANHATTAN WEST,395 9TH AVENUE, 58 FL, NEW YORK NY 10001
Van Ommen Nick J.m. director C/O W. P. CAREY & CO. LLC, ONE MANHATTAN WEST, 395 9TH AVE. 58 FL, NEW YORK NY 10001